Related Experiment Video
Updated: Apr 14, 2026
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Role of Merlin/NF2 inactivation in tumor biology
A M Petrilli1, C Fernández-Valle1
1Department of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA.
Abstract:
Merlin (Moesin-ezrin-radixin-like protein, also known as schwannomin) is a tumor suppressor protein encoded by the neurofibromatosis type 2 gene NF2. Loss of function mutations or deletions in NF2 cause neurofibromatosis type 2 (NF2), a multiple tumor forming disease of the nervous system. NF2 is characterized by the development of bilateral vestibular schwannomas. Patients with NF2 can also develop schwannomas on other cranial and peripheral nerves, as well as meningiomas and ependymomas. The only potential treatment is surgery/radiosurgery, which often results in loss of function of the involved nerve. There is an urgent need for chemotherapies that slow or eliminate tumors and prevent their formation in NF2 patients. Interestingly NF2 mutations and merlin inactivation also occur in spontaneous schwannomas and meningiomas, as well as other types of cancer including mesothelioma, glioma multiforme, breast, colorectal, skin, clear cell renal cell carcinoma, hepatic and prostate cancer. Except for malignant mesotheliomas, the role of NF2 mutation or inactivation has not received much attention in cancer, and NF2 might be relevant for prognosis and future chemotherapeutic approaches. This review discusses the influence of merlin loss of function in NF2-related tumors and common human cancers. We also discuss the NF2 gene status and merlin signaling pathways affected in the different tumor types and the molecular mechanisms that lead to tumorigenesis, progression and pharmacological resistance.
Insights
Merlin (Moesin-ezrin-radixin-like protein) loss of function due to NF2 gene mutations drives neurofibromatosis type 2 tumors and other cancers. Understanding merlin's role is crucial for developing new cancer therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Merlin (Moesin-ezrin-radixin-like protein), encoded by the NF2 gene, is a tumor suppressor.
- Loss-of-function mutations in NF2 cause neurofibromatosis type 2 (NF2), leading to nervous system tumors like vestibular schwannomas, meningiomas, and ependymomas.
- NF2 mutations are also implicated in various other cancers, including mesothelioma, glioma, and breast cancer.
Purpose of the Study:
- To review the impact of merlin loss-of-function in NF2-related tumors and common human cancers.
- To explore the NF2 gene status and merlin signaling pathways in different tumor types.
- To discuss molecular mechanisms underlying tumorigenesis, progression, and therapeutic resistance.
Main Methods:
- Literature review of studies on NF2 gene mutations and merlin protein function.
- Analysis of NF2 gene status and merlin signaling in various human cancers.
- Discussion of molecular mechanisms of tumorigenesis and therapeutic resistance.
Main Results:
- Merlin loss-of-function is a key driver in NF2-related tumors and contributes to other cancers.
- NF2 mutations and merlin inactivation are relevant for cancer prognosis and potential therapeutic strategies.
- Understanding merlin's role in signaling pathways is critical for comprehending tumorigenesis.
Conclusions:
- Merlin plays a significant role in tumor suppression, and its inactivation is linked to diverse cancers.
- Further research into NF2 gene status and merlin pathways can inform novel chemotherapeutic approaches.
- Targeting merlin signaling may offer new avenues for cancer treatment and prevention.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Related Concept Videos
02:38Mitogens and the Cell Cycle
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...